Breaking News
0

Sunesis Pharmaceuticals Inc (SNSS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sunesis Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.1477 +0.0177    +1.57%
13:38:16 - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US8673287004 
CUSIP: 867328700
  • Volume: 135,390
  • Bid/Ask: 1.1300 / 1.1500
  • Day's Range: 1.1100 - 1.2900
Sunesis Pharma 1.1477 +0.0177 +1.57%

SNSS Overview

 
Information about the Sunesis Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close1.13
Day's Range1.11 - 1.29
Revenue240K
Open1.17
52 wk Range1.11 - 7.69
EPS - 0.8
Volume135,390
Market Cap42.29M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)220,973
P/E RatioN/A
Beta2.09
1-Year Change - 60.49%
Shares Outstanding37,421,509
Next Earnings DateMar 07, 2019
What is your sentiment on Sunesis Pharma?
or
Vote to see community's results!

Sunesis Pharmaceuticals Inc News


Sunesis Pharmaceuticals beats by $0.01
Sunesis Pharmaceuticals beats by $0.01
By Seeking Alpha - Nov 05, 2018

Sunesis Pharmaceuticals (SNSS): Q3 GAAP EPS of -$0.18 beats by $0.01. Cash and equivalents of $20.16M Press Release

Sunesis Pharmaceuticals Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bullish 30 Current
Harami Cross 5H Current
Completed Patterns
Bullish Engulfing 1M 4 Jul 18
Three Black Crows 1W 4 Oct 21, 2018
Three Inside Up 30 5 Nov 20, 2018 10:30AM

Sunesis Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 1.1477 1.1300 1.1500 135,390 +1.57% USD 13:38:16  
  Stuttgart 1.080 1.660 1.710 0 +0.00% EUR 16/11  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 178.91 181.47 175.52 -6.95 -3.74% 45.93M 13:43:35  
  Amazon.com 1,506.99 1,534.75 1,420.00 -5.30 -0.35% 8.41M 13:43:33  
  Facebook 132.13 134.15 126.85 +0.58 +0.44% 29.02M 13:43:40  
  NVIDIA 149.72 154.26 133.32 +5.02 +3.47% 34.52M 13:43:40  
  Netflix 269.72 276.34 250.00 -0.88 -0.33% 12.94M 13:43:40  
  AMD 19.31 19.58 17.18 +0.20 +1.06% 87.60M 13:43:44  
  Micron 36.21 36.99 34.05 -0.62 -1.68% 29.12M 13:43:40  
  Tesla 343.53 349.71 333.55 -9.94 -2.81% 5.91M 13:43:40  
  General Electric 7.67 7.86 7.53 -0.17 -2.17% 82.32M 13:43:41  
  Alibaba 146.37 148.05 142.87 -3.16 -2.11% 12.66M 13:43:39  

Sunesis Pharmaceuticals Inc Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

34

Equity Type

ORD

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNSS Comments

Write your thoughts about Sunesis Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feb 05, 2018 5:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i suggest SNSS has seen it's highs for now.
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email